Theriva Biologics Inc (AMEX:TOVX) price on Thursday, July 03, fall -1.56% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.44.
A look at the stock’s price movement, the close in the last trading session was $0.45, moving within a range at $0.4318 and $0.45. The beta value (5-Year monthly) was 0.833. Turning to its 52-week performance, $7.37 and $0.40 were the 52-week high and 52-week low respectively. Overall, TOVX moved -5.74% over the past month.
Theriva Biologics Inc’s market cap currently stands at around $4.02 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TOVX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
TOVX’s current price about -3.36% and -33.69% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 36.68, while 7-day volatility ratio is 5.38% and 7.94% in the 30-day chart. Further, Theriva Biologics Inc (TOVX) has a beta value of 0.76.
If we refocus on Theriva Biologics Inc (AMEX:TOVX), historical trading data shows that trading volumes averaged 0.12 over the past 10 days and 1.42 million over the past 3 months. The company’s latest data on shares outstanding shows there are 9.06 million shares.
The 1.04% of Theriva Biologics Inc’s shares are in the hands of company insiders while institutional holders own 2.11% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.25 million on 2025-06-13, giving us a short ratio of 0.16. The data shows that as of 2025-06-13 short interest in Theriva Biologics Inc (TOVX) stood at 305.0 of shares outstanding, with shares short rising to 0.17 million registered in 2025-05-15. Current price change has pushed the stock -92.66% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TOVX stock continues to rise going into the next quarter.
